Speciality Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve 1. Audited Standalone Financial Statements of the company for the financial year ended on March 31 2026. 2. To consider approve and take on record Audited Standalone Financial Results of the company for the half year and the financial Year ended on March 31 2026 as per Regulation 33 of Listing Regulations.3. Any other matter with the permission of the Chairman.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
